Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women

Bone

Volumn 28, Issue 1, 2001, Pages 113-117

  Martini, G ^a   Valenti, R ^a   Giovani, S ^a   Franci, B ^a   Campagna, S ^a   Nuti, R ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Body composition; Bone mineral density (BMD); Bone turnover; Insulin like growth factor 1 (IGF 1); Leptin; Postmenopausal women

Indexed keywords

LEPTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; ITALY; NORMAL HUMAN; POSTMENOPAUSE;

ADULT; AGED; AGED, 80 AND OVER; AGING; BODY COMPOSITION; BONE DENSITY; BONE REMODELING; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MIDDLE AGED; POSTMENOPAUSE;

EID: 0035155707     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(00)00408-7     Document Type: Article

References (47)

1. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults
2. Gender differences in insulin-like growth factor and bone mineral density association in old age; The Rancho Bernardo Study
3. The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults
4. Age-associated decline in human femoral neck cortical and trabecular content of insulin-like growth factor I; Potential implications for age-related (Type II) osteoporotic fracture occurrence
5. Age-related endocrine deficiencies and fractures of the proximal femur. Implications of growth hormone deficiency in the elderly
6. Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70 years; Potential implications for the prevention of age-related bone loss
7. Insulin-like growth factors and osteoporosis
8. The insulin-like growth factor axis and plasma lipid levels in the elderly
9. Insulin-like growth factor-I and bone mineral density
10. Serum immunoreactive-leptin concentration in normal weight and obese humans
11. Human growth hormone and human aging
12. Localization of the leptin receptor in the human brain
13. Free insulin like growth factors in human obesity
14. Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women
15. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification
16. Effects of recombinant human growth hormone on metabolic indices, body composition and bone turnover in healthy elderly women
17. Reduced bone mineral density in patients with adult onset growth hormone deficiency
18. Insulin like growth factors and their binding proteins; Biological actions
19. Serum levels of insulin like growth factors (IGF) binding protein 3 (IGFBP-3) in healthy infants, children and adolescents; The relation to IGF-I. IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index and pubertal maturation
20. No evidence for reduced spontaneous or growth-hormone stimulated levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis
21. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset
22. Leptin and bone mineral density (BMD) in older men and women
23. Association between insulin-like growth factor I and bone mineral density in older women and men; The Framingham heart study
24. Leptin stimulates cortical bone formation in obese mice
25. The relationship between insulin-like growth factor-I concentrations, knee osteoarthritis, bone density and fractures in the general population; The Chingford study
26. Leptin levels in human and rodent; Measurement of plasma leptin and of RNA in obese and weight-reduced subjects
27. Age-related changes in body composition of healthy and osteoporotic women
28. Leptin is inversely related to age at menarche in human females
29. Dual-energy x-ray absorptiometry for total-body and regional bone mineral and soft-tissue composition
30. Age-related decreases in insulin-like growth factor-I and transforming growth factor-beta in femoral cortical bone from both men and women; Implications for bone loss with aging
31. Total body, spine, and femur dual X-ray absorptiometry in spinal osteoporosis
32. Comparison of total body measurements by dual-energy x-ray absorptiometry and dual-photon absorptiometry
33. Serum leptin concentrations in a normal population and in GH deficiency; Negative correlation with testosterone in men and effects of GH treatment
34. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians; Relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function
35. The influence of endurance training on insulin-like growth factors-1 in older subjects
36. Menopause-associated changes in plasma lipids, insulin-like growth factor-I, and blood pressure; A longitudinal study
37. Does leptin have an effect on bone in adult women?
38. Insulin-like growth factors I, and II in healthy women with and without established osteoporosis
39. Effect of estrogen deficiency on IGF-I plasma levels; Relationship with bone mineral density in perimenopausal women
40. Obesity
41. Insulin like growth factors and their binding proteins
42. Age-related changes in insulin-like growth factor I and II in human femoral cortical bone; Lack of correlation with bone mass
43. Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women; Relationship to age, menopause, bone turnover, bone volume, and circulating IGFs
44. Serum levels of insulin-like growth factor (IGF)-I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures
45. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes
46. Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral; A cross sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study
47. Decreased serum levels of insulin-like growth factors and IGF-binding protein-3 in osteoporosis